Manager × security

Blue Owl Capital Holdings LP LRMR holdings history

Who else holds this security? →

LARIMAR THERAPEUTICS INC · CUSIP 517125100 · CIK 1858703

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Blue Owl Capital Holdings LP reported 9.16M LRMR (shares), valued at $27.95M, or 4.25% of its reported non-derivative portfolio. Filed 2026-08-11.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
4.25%
Shares
9.16M
9,163,157
Reported value
$27.95M
USD

Shares increased 28.70%; reported value decreased 12.77%, and weight changed -4.36 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20264.25%9,163,157SEC filing ↗Filed Aug 11, 2026
Q1 20268.61%7,120,007SEC filing ↗Filed May 14, 2026
Q4 20258.02%6,823,690SEC filing ↗Filed Feb 20, 2026Amended
Q3 20255.87%5,853,040SEC filing ↗Filed Nov 12, 2025
Q2 20254.60%4,928,040SEC filing ↗Filed Aug 11, 2025
Q1 20253.31%4,778,040SEC filing ↗Filed May 15, 2025
Q4 20244.15%4,653,040SEC filing ↗Filed Feb 14, 2025
Q3 20245.29%4,166,829SEC filing ↗Filed Nov 14, 2024
Q2 20247.78%3,859,468SEC filing ↗Filed Aug 15, 2024
Q1 20246.06%3,994,468SEC filing ↗Filed May 15, 2024
Q4 20233.71%3,414,468SEC filing ↗Filed Feb 15, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20233.71%3,414,468$15.54MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 15, 2024
Q1 20246.06%3,994,468$30.32MShares increased 16.99%; reported value increased 95.15%, and weight changed +2.35 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20247.78%3,859,468$27.98MShares decreased 3.38%; reported value decreased 7.71%, and weight changed +1.72 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 15, 2024
Q3 20245.29%4,166,829$27.29MShares increased 7.96%; reported value decreased 2.46%, and weight changed -2.49 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20244.15%4,653,040$18.01MShares increased 11.67%; reported value decreased 34.02%, and weight changed -1.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20253.31%4,778,040$10.27MShares increased 2.69%; reported value decreased 42.95%, and weight changed -0.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20254.60%4,928,040$14.24MShares increased 3.14%; reported value increased 38.64%, and weight changed +1.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2025
Q3 20255.87%5,853,040$18.91MShares increased 18.77%; reported value increased 32.74%, and weight changed +1.27 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2025
Q4 20258.02%6,823,690$26.00MShares increased 16.58%; reported value increased 37.52%, and weight changed +2.15 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 20, 2026
Q1 20268.61%7,120,007$32.04MShares increased 4.34%; reported value increased 23.24%, and weight changed +0.59 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 20264.25%9,163,157$27.95MShares increased 28.70%; reported value decreased 12.77%, and weight changed -4.36 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2026
Blue Owl Capital Holdings LP · LARIMAR THERAPEUTICS INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1858703","quarter":"2026Q2","cusip":"517125100"}

get_institutional_manager_history
{"cik":"1858703","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.